# Abpro Bio — South Korea ## No corporate parent is shown 0 ownership levels above this company 0 supply relationships in public sources · 0 with suppliers, 0 with customers 1 counterparties named from licensed supply-chain data · 1 customer 0 linked facilities 0 export-control designations found 0 sovereign commitments to funds investing in this company Scrutica id org-abpro-bio Page actionsCite PrintScreenshot ### Ownership chain The main chain follows the strongest parent claim by confidence, source authority and date; other named parents appear beside it. A holding reviewed as conferring no control is listed under the company it is held in, never as its parent. 1. Abpro Bio (KR) Starting organisation. End of the displayed chain The displayed [ownership chain](https://scrutica.com/methodology#chain-of-title-walk) ends at **Abpro Bio** ### Suppliers and customers Licensed supply-chain database A licensed supply-chain database records 1 customer of Abpro Bio, named here by headquarters country. The database’s own figures are withheld. Customers · 1 South Korea · 1 [Samsung](https://scrutica.com/companies/org-samsung) ### Related analysis - [Headquarters country: South Korea Country profile with facility capacity, government AI programmes and export-control conditions. ](https://scrutica.com/country/kr) Source coverage Licensed supply-chain records are available for this company. Geographic revenue, business segments and capital allocation are unavailable from the licensed financial dataset. No stock ticker or SEC filing identifier is recorded for Abpro Bio. The public industry classification (SIC, NAICS) is also unrecorded. [Sources and publication limits](https://scrutica.com/methodology#licensed-substrate).